Should Medicare Negotiate More Drug Prices?
Medicare has begun negotiating prices on a small set of drugs. Congress could expand that authority to many more medications — or pull it back. Americans pay more for prescriptions than any other wealthy country. Where do you stand?
Weigh in
The case for
Supporters say expanded negotiation and out-of-pocket caps would bring US prices toward what other countries pay and end the choice between medication and groceries for seniors.
Source: AARP (supports negotiation) →The case against
Opponents argue negotiation at Medicare's scale is effectively price-setting, which could shrink the research pipeline for new cures — and note most breakthrough drugs are developed for the US market first.
Source: PhRMA (pharmaceutical industry, opposes) →My Democracy doesn’t take a side — you choose your position below, and your message carries it. Sources represent one organization on each side; they don’t reflect My Democracy’s position.
10 more to reach 10
Take Action
What’s your position?
Both sides are laid out above. Your message will carry your position — My Democracy doesn’t take a side.